COMPREHENSIVE GUIDE TO HEPATITIS ADVANCES

Section 1:HEPATITIS: ADVANCES IN CLINICAL EVALUATION
1. Noninvasive assessment of liver disease severity: image-related
2. Comprehensive guide to advances in hepatitis noninvasive assessments of disease severity: biomarkers
3. Conventional liver imaging in hepatitis
3. Nutrition and the liver
4. Nutrition in liver disease

Section II: VIRAL HEPATITIS
5. Antivirals against hepatitis viruses: basic mechanisms
6. Hepatitis A and hepatitis E
7. Hepatitis B: epidemiology, natural history, and diagnosis
8. Hepatitis B: treatment
9. Hepatitis C: epidemiology, natural history, and diagnosis
10. Hepatitis C: treatment
11. Hepatitis D

Section III: HEPATITIS: METABOLIC, ALCOHOL, AND DRUG INDUCED
12. Metabolic-associated fatty liver disease: epidemiology, natural history and diagnosis, current paradigm and definitions for MAFLD
13. Metabolic-associated fatty liver disease: pharmacological management
14. Nonpharmacological treatment approach in patients with metabolic dysfunctionassociated liver disease
15. Alcoholic hepatitis
16. Drug-induced liver injury caused by conventional drugs, using cases based on the Roussel Uclaf causality assessment method
17. Introduction to drug-induced liver injury

Section IV: HEPATITIS: CHOLESTATIC, GENETIC, AND AUTOIMMUNE CAUSES
18. Current paradigm and treatment options for autoimmune hepatitis
19. Hereditary hemochromatosis
20. Wilson disease
21. AATD chapter for “comprehensive guide to hepatitis advances” book edited by Seto and Eslam

Section V: HEPATITIS: INFECTIONS AND SYSTEMIC CAUSES
22. Hepatitis: infections and systemic causes
23. HIV: hepatic manifestations of HIV and antiretroviral therapy
24. Systemic noninfectious hepatitis
25. Concurrent HCV or fatty liver in patients with chronic hepatitis B virus infection

Section VI: CHILDHOOD AND PREGNANCY
26. Hepatitis during childhood
27. Hepatitis during pregnancy

• Provides comprehensive coverage of the different types of hepatitis
• Highlights the most recent research findings related to different types of hepatitis and their impact on clinical care
• Discusses future development specific to different types of hepatitis

Author
• Wai-Kay Seto, MBBS(HK) MD(HK) MRCP (UK) FRCP (Edin, Glasg, Lond) FHKCP FHKAM (Medicine), Clinical Professor, School of Clinical Medicine and State Key Laboratory of Liver Research, The University of Hong Kong, Hong Kong.
• Mohammed Eslam, Professor of hepatology, Storr Liver Centre, Westmead Institute for Medical Research, Westmead Hospital and University of Sydney, Australia